COMARCO INC
Categories of dependency expected for this filer that were actually found stated in Risk Factors / MD&A.
- Filing
- 0001437749-17-007521 (10-K)
- Period
- 2016-02-01 to 2017-01-31
- XBRL tag
- us-gaap:SalesRevenueNet
- Context
- d_2016-02-01_2017-01-31
- Mapping
- seed · confidence 1.00
Extracted from Risk Factors / MD&A, checked verbatim against the source text before being stored.
“If we do not improve our cash position in the near term, we may be forced to cease operations, in which event you may lose your entire investment in us.”
“We currently have no commitments for any additional financing and there can be no assurance that we will be able to obtain requisite financing on acceptable terms, if at all.”
“our ability to retain counsel on an alternative fee structure basis or otherwise fund the cost of litigation and litigation counsel”
“we may not have sufficient capital to continue to prosecute and maintain our existing patents or new or existing patent applications.”
“Because our common stock is not listed on a national securities exchange, you may find it difficult to buy or sell or obtain quotations for our common stock”
“the validity of our claims, our ability to succeed on the merits of our claims, interpretation of applicable contracts and laws (which in many cases are complex and potentially subject to competing interpretations)”
“it is likely that we will become subject to counterclaims in any litigation to which we are a party, which may result in us being subject to damages or other obligations.”
“Third parties may claim that we are infringing their intellectual property, and we could suffer significant litigation, settlement or licensing costs and expenses.”